complement
major
element
innat
immun
respons
also
serv
link
innat
adapt
immun
ancient
immunolog
defenc
system
thought
evolv
million
year
ago
compon
identifi
vertebr
class
zarkadi
et
al
complement
compris
serum
membranebound
protein
activ
form
cascad
reaction
contribut
elimin
invad
microorgan
three
pathway
activ
exist
classic
lectin
altern
pathway
outlin
fig
review
walport
invok
sever
respons
capabl
control
elimin
infect
overview
focu
interact
virus
complement
highlight
protect
role
complement
viral
infect
mechan
use
virus
evad
effect
complement
way
virus
exploit
complement
enhanc
infect
aim
provid
comprehens
analysi
rather
overview
interact
virus
complement
intent
emphasis
grow
recognit
import
complement
viru
biolog
reveal
increas
number
virus
known
either
activ
passiv
strategi
complement
regul
activ
complement
activ
potenti
damag
host
cell
must
therefor
tightli
regul
reason
activ
compon
short
halfliv
regul
larg
famili
host
plasma
membranebound
protein
involv
physiolog
control
mani
stage
complement
cascad
exampl
mammalian
complement
control
protein
given
tabl
complement
regul
base
upon
three
principl
mechan
acceler
dissoci
enzym
cleav
socal
convertas
complex
mediat
cascad
complement
activ
ii
enzymat
cleavag
inactiv
compon
iii
inactiv
follow
irrevers
bind
inhibitor
host
protein
involv
regul
complement
includ
inhibitor
group
protein
known
regul
complement
activ
rca
review
morgan
harri
rca
protein
contain
structur
motif
known
short
consensu
repeat
scr
scr
compris
amino
acid
conserv
motif
disulphidelink
cystein
sever
hydrophob
residu
rca
protein
regul
complement
compon
resist
mechan
adopt
nucleat
cell
includ
express
ectoproteas
surfac
inactiv
complement
compon
cleavag
nucleat
mammalian
cell
also
avoid
lysi
termin
complement
membran
attack
complex
mac
see
shed
endocytosi
vesicl
enrich
mac
compon
carney
et
al
carney
et
al
scold
et
al
viru
infect
activ
three
pathway
complement
cascad
see
fig
classic
pathway
activ
bind
complement
compon
antibodi
antigen
complex
activ
also
achiev
bind
directli
glycoprotein
virus
absenc
specif
antibodi
virus
includ
human
cytomegaloviru
hcmv
spiller
morgan
certain
retrovirus
cooper
et
al
solder
et
al
human
cell
lymphotrop
viru
htlv
ikeda
et
al
lectin
pathway
antibodyindepend
activ
upon
interact
mannanbind
lectin
mbl
viral
surfac
carbohydr
pathway
implic
control
sever
viral
infect
includ
hepat
b
viru
hbv
wang
influenza
hartshorn
et
al
thielen
et
al
third
pathway
altern
pathway
origin
defin
antibodyindepend
activ
pathway
lectin
pathway
discov
decad
later
activ
altern
pathway
trigger
continu
lowlevel
spontan
releas
intern
thioester
bond
form
tightli
regul
convertas
convertas
may
either
exist
fluid
phase
attach
cell
surfac
spontan
event
occur
near
cell
importantli
activ
altern
pathway
occur
foreign
activ
surfac
determin
lack
factor
h
bind
surfac
factor
h
bind
regul
altern
pathway
depend
addit
sialic
acid
carbohydr
found
cell
surfac
decreas
follow
infect
virus
complement
activ
three
pathway
result
sever
effector
function
contribut
viru
inactiv
elimin
function
includ
opsonis
virion
complement
compon
promot
phagocytosi
virolysi
mac
enhanc
sever
arm
immun
respons
product
anaphylatoxin
chemotact
factor
effector
function
discuss
complement
compon
bind
virion
surfac
form
protein
coat
opsonis
neutralis
viral
infect
varieti
way
phagocyt
cell
surfac
receptor
recognis
bind
promot
uptak
destruct
virion
cover
compon
review
hannan
et
al
krychgoldberg
atkinson
mcgreal
gasqu
coval
attach
virion
surfac
may
also
prevent
viral
interact
receptor
uncoat
entri
host
cell
inde
coat
sever
virus
includ
human
immunodefici
viru
hiv
shown
function
inactiv
viru
vitro
vivo
sullivan
et
al
aggreg
viral
particl
due
bind
multival
complement
compon
antibodi
neutralis
viru
infect
also
promot
phagocytosi
via
fc
receptor
although
opsonis
inactiv
infecti
virion
envelop
virus
also
suscept
lysi
mac
amphipath
complement
compon
combin
insert
viral
envelop
form
transmembran
channel
channel
result
bidirect
flow
ion
macromolecul
disrupt
viral
integr
eventu
lead
osmot
lysi
irrevers
loss
viral
activ
alphavirus
coronavirus
herpesvirus
retrovirus
suscept
kill
mac
mochizuki
et
al
spear
et
al
vasantha
et
al
enzymat
cleavag
complement
compon
complement
activ
result
product
low
molecular
weight
biolog
activ
peptid
anaphylatoxin
respect
see
fig
overal
anaphylatoxin
activ
mani
cell
type
concomit
wide
rang
cell
receptor
express
review
ember
hugli
kohl
mediat
mani
inflammatori
respons
includ
smooth
muscl
contract
enhanc
vascular
permeabl
releas
vasoact
amin
induct
lysosom
enzym
releas
potent
anaphylatoxin
function
chemoattract
leukocyt
neutrophil
recruit
region
complement
activ
inflamm
may
also
act
chemotact
factor
eosinophil
cell
complement
play
import
role
induct
humor
immun
virus
see
fig
ii
opsonis
virion
bind
follicular
dendrit
cell
fdc
lymph
node
via
complement
receptor
serv
enhanc
viral
antigen
present
b
cell
see
fig
ii
combin
viral
antigen
also
induc
crosslink
b
cell
antigen
receptor
b
cell
surfac
inde
shown
mice
defici
variou
complement
compon
fail
develop
normal
memori
respons
herp
simplex
viru
hsv
da
costa
et
al
furthermor
antigen
hiv
envelop
glycoprotein
encod
env
viral
antigen
augment
creat
dna
vaccin
evalu
mice
wherebi
env
fuse
human
murin
gene
encod
green
et
al
hypocomplementaemia
medic
term
use
defin
condit
compon
complement
lack
reduc
concentr
although
defici
compon
complement
rare
patient
hypocomplementaemia
shown
suscept
infect
diseas
certain
virus
exampl
posit
correl
hepat
c
viru
hcv
viraemia
hypocomplementaemia
demonstr
furthermor
sever
frequenc
hsv
reactiv
nonrespons
hbv
vaccin
link
defici
hohler
et
al
seppanen
et
al
virus
evolv
numer
mechan
evad
destruct
effect
complement
includ
passiv
strategi
exampl
cellular
complement
regulatori
protein
may
incorpor
envelop
virus
bud
cell
surfac
activ
strategi
certain
virus
encod
complement
regulatori
protein
mechan
discuss
see
also
favoreel
et
al
lee
et
al
incorpor
host
rca
protein
egress
host
cell
mechan
utilis
envelop
virus
protect
cellfre
virion
complementmedi
attack
exact
mechan
process
unknown
may
involv
viral
bud
certain
region
cell
surfac
enrich
complement
regulatori
protein
lipid
raft
variou
isol
hiv
immunocaptur
antimembran
cofactor
protein
mcp
antidecay
acceler
factor
daf
antibodi
incorpor
three
protein
demonstr
protect
virion
complementmedi
lysi
saifuddin
et
al
vaccinia
viru
vv
htlv
hcmv
exampl
virus
incorpor
host
complement
regulatori
protein
envelop
afford
protect
complement
virus
includ
psuedorabi
viru
prv
swine
aherpesviru
shed
internalis
antibodi
common
three
pathway
format
convertas
enzym
complex
convertas
cleav
chemotaxin
latter
protein
form
convertas
cleav
anaphylatoxin
product
enabl
format
lytic
pore
known
membran
attack
complex
mac
activ
classic
pathway
result
bind
two
immunoglobulin
fc
region
antigenbound
igg
igm
bind
induc
autolyt
cleavag
subsequ
cleavag
activ
activ
cleav
result
bind
coval
cell
surfac
enabl
bind
cleav
complex
gener
classic
convertas
ii
lectin
pathway
trigger
ident
manner
except
recogn
mannanbind
lectin
mbl
foreign
carbohydr
activ
mblassoci
serin
proteas
masp
capabl
cleav
creat
convertas
three
separ
masp
identifi
form
convertas
review
schwaebl
et
al
iii
altern
pathway
continu
activ
amplifi
activ
surfac
insuffici
regul
also
serv
convertas
amplif
loop
two
pathway
altern
pathway
trigger
constant
lowlevel
spontan
cleavag
occur
nonspecif
releas
intern
thioester
bond
result
hydrolys
either
fluid
phase
cellbound
form
complex
factor
b
fb
cleav
serum
proteas
factor
fd
complex
gener
result
format
altern
pathway
convertas
stabilis
associ
serum
protein
properdin
shown
iv
gener
previou
activ
pathway
associ
noncoval
associ
enabl
loos
interact
membran
surfac
strengthen
subsequ
noncoval
associ
caus
insert
complex
membran
full
membran
attack
complex
consist
lytic
pore
form
incorpor
molecul
b
complement
regul
sever
mechan
see
also
tabl
surfacebound
serum
protein
acceler
decay
convertas
mani
case
ii
subsequ
induc
factor
fi
cleavag
coval
attach
compon
convertas
fragment
longer
bind
see
ai
aii
fb
see
aiii
iii
convers
regul
act
suicid
irrevers
associ
either
termin
complement
compon
initi
complex
classic
pathway
inhibitor
result
subsequ
remov
proteas
complex
antigen
complex
surfac
prevent
complement
activ
phagocytosi
van
de
wall
et
al
son
johansson
dowler
veltri
litwin
grose
regard
bind
nonimmun
igg
cell
shown
protect
complementmedi
lysi
protect
virion
antibodi
neutralis
dowler
veltri
hiv
report
impair
complementmedi
phagocytosi
infect
cell
possibl
interf
downstream
signal
event
kedzierska
et
al
larger
dna
virus
genom
capac
encod
protein
complement
regulatori
activ
sever
characteris
extens
mani
protein
identifi
base
homolog
cellular
complement
regulatori
protein
includ
gc
glycoprotein
show
homolog
cellular
protein
thu
may
regul
complement
differ
mechan
see
mani
member
herpesviru
poxviru
famili
encod
complement
control
protein
homologu
known
inhibit
antivir
effect
complement
differ
mechan
three
gherpesvirus
kaposi
sarcoma
associ
herpesviru
kshv
herpesviru
saimiri
hv
murin
gherpesviru
encod
protein
kcp
ccph
respect
homolog
daf
mcp
inhibit
complement
activ
fodor
et
al
kapadia
et
al
spiller
et
al
kshv
kcp
compris
three
protein
isoform
thought
produc
altern
splice
regul
complement
activ
spiller
et
al
kcp
prevent
cell
surfac
deposit
enhanc
decay
classic
pathway
convertas
act
cofactor
factor
imedi
cleavag
reaction
see
fig
ii
mullick
et
al
spiller
et
al
spiller
et
al
hv
ccph
protein
show
similar
activ
kcp
inhibit
deposit
convertas
activ
fodor
et
al
second
distinct
complement
regulatori
protein
encod
hv
thought
control
complement
activ
block
format
termin
mac
albrecht
et
al
rca
protein
inhibit
complement
activ
classic
altern
pathway
kapadia
et
al
recent
rca
delet
mutant
creat
evalu
contribut
complement
control
protein
viral
pathogenesi
vivo
kapadia
et
al
result
indic
rca
protein
requir
full
virul
acut
chronic
infect
attenu
phenotyp
mutant
could
revers
delet
host
complement
also
shown
role
regul
latenc
find
demonstr
potenti
import
complement
gherpesviru
infect
virus
evolv
success
strategi
evad
complement
poxvirus
cowpox
variola
vv
encod
function
homologu
complement
control
protein
vv
complement
control
protein
vcp
extens
characteris
vcp
acceler
decay
classic
altern
pathway
convertas
act
cofactor
factor
imedi
cleavag
mckenzi
et
al
sahu
et
al
vcp
secret
infect
cell
contribut
virul
anim
model
prevent
antibodycompl
depend
neutralis
vv
isaac
et
al
gc
glycoprotein
characteris
viral
complement
control
protein
lack
homolog
host
complement
regulatori
protein
first
viral
protein
identifi
bind
complement
friedman
et
al
fri
et
al
although
gc
glycoprotein
highli
homolog
one
anoth
demonstr
signific
differ
abil
regul
complement
gc
acceler
decay
altern
pathway
convertas
protect
complement
activ
pathway
hung
et
al
gc
mutant
incap
bind
complement
shown
reduc
pathogen
anim
model
infect
lubinski
et
al
gc
acceler
decay
altern
pathway
convertas
provid
protect
complementmedi
neutralis
howev
compar
gc
protein
gc
demonstr
poor
complement
regulatori
activ
epstein
barr
viru
ebv
also
complement
regulatori
activ
mold
et
al
encod
protein
show
homolog
host
complement
regulatori
protein
highlight
much
remain
understood
viral
protein
upregul
host
rca
surfac
infect
cell
demonstr
hcmv
mcp
daf
express
upregul
spiller
et
al
although
mechan
regul
determin
upregul
daf
shown
increas
resist
infect
cell
complement
mediat
lysi
howev
mechan
murin
cmv
upregul
mcp
determin
depend
cisact
virusrespons
promot
element
mcp
promot
nomura
et
al
virus
may
recruit
protect
host
complement
compon
surfac
surfac
infect
cell
addit
incorpor
rca
protein
envelop
hiv
bind
factor
h
surfac
interact
glycoprotein
stoiber
et
al
bind
shown
significantli
protect
virion
effect
complement
stoiber
et
al
promot
degrad
bound
enhanc
abil
hiv
interact
fdc
sindbi
viru
thought
incorpor
host
sialic
acid
envelop
bud
amount
sialic
acid
cell
infect
viru
posit
correl
resist
complement
presum
abil
recruit
bind
factor
h
hirsch
et
al
mimick
host
surfac
way
may
help
avoid
complement
activ
altern
pathway
latenc
may
also
serv
mechan
evad
complement
prevent
express
viral
antigen
cell
surfac
could
target
cell
complementmedi
destruct
howev
virus
undergo
latent
infect
must
abil
evad
complement
attack
reactiv
certain
herpesvirus
seem
see
mani
virus
exploit
complement
system
promot
infect
either
direct
bind
complement
receptor
cr
gain
entri
host
cell
indirectli
complementopsonis
viru
interact
cr
express
mani
tissu
cell
includ
neutrophil
fdc
b
cell
macrophag
import
role
clear
immun
complex
well
neutrophil
function
well
establish
ebv
gain
entri
b
cell
endotheli
cell
interact
viral
protein
complement
receptor
fingeroth
et
al
although
receptor
certain
integrin
also
shown
involv
tugizov
et
al
kinet
studi
indic
higher
affin
host
fragment
would
effect
surpass
host
bind
moor
et
al
complement
regul
also
target
viral
bind
mcp
recent
identifi
receptor
group
badenovirus
sinc
nonpermiss
cell
render
suscept
viral
infect
express
mcp
gaggar
et
al
segerman
et
al
human
herpesviru
measl
viru
mv
use
mcp
cellular
receptor
although
utilis
differ
domain
receptor
bind
greenston
et
al
identif
mcp
receptor
mv
led
develop
transgen
mous
model
contribut
vivo
studi
viral
pathogenesi
horvat
et
al
rall
et
al
howev
primari
mv
receptor
signal
lymphocyteactiv
molecul
slam
tatsuo
et
al
part
complement
system
nevertheless
lack
slam
central
nervou
system
cn
suggest
utilis
mcp
mv
may
determin
develop
sever
cn
complic
subacut
scleros
panenceph
sometim
associ
mv
infect
sever
virus
includ
mani
enterovirus
echoviru
certain
coxsacki
virus
use
daf
coreceptor
bergelson
et
al
martino
et
al
shafren
spiller
et
al
bind
may
suffici
enabl
viral
entri
rather
serv
facilit
interact
accessori
molecul
henc
use
term
coreceptor
close
relat
picornavirus
bind
daf
shown
interact
differ
scr
daf
protein
powel
et
al
coat
viral
surfac
complement
compon
may
enhanc
infect
virus
includ
west
nile
viru
hiv
via
interact
virusbound
complement
compon
host
cr
cardosa
et
al
robinson
et
al
saifuddin
et
al
stoiber
et
al
hiv
either
opsonis
complement
immunocomplex
complement
fragment
plu
antibodi
associ
effici
cell
express
cr
includ
fdc
macrophag
monocyt
b
cell
associ
facilit
infect
andneg
cell
exampl
infect
could
promot
lymphocyt
traffick
lymphoid
tissu
hiv
trap
highdens
cr
express
fdc
moir
et
al
anaphylatoxin
also
shown
increas
suscept
monocytederiv
macrophag
hiv
infect
kacani
et
al
clearli
interact
hiv
complement
complex
fine
balanc
must
exist
viral
neutralis
enhanc
infect
complement
import
mediat
inflamm
inappropri
prolong
activ
undesir
effect
complement
activ
may
contribut
patholog
mani
diseas
includ
ischaemia
reperfus
injuri
adult
respiratori
distress
syndrom
sever
autoimmun
diseas
makrid
reason
mani
human
complement
inhibitor
current
investig
therapeut
agent
target
variou
stage
complement
cascad
sever
inhibitor
current
clinic
trial
holer
smith
smith
mani
potenti
therapeut
agent
identifi
date
inde
rang
viral
protein
exhibit
complementregulatori
activ
numer
stage
complement
cascad
could
also
exploit
search
novel
agent
target
complement
viral
protein
may
higher
affin
complement
compon
host
regulatori
protein
case
ebv
bind
via
viral
glycoprotein
moor
et
al
howev
immunogen
viral
protein
would
requir
consider
virus
current
common
vector
develop
test
gene
therapi
trial
correct
defect
gene
oncolyt
virus
may
also
utilis
tumour
therapi
wakimoto
et
al
virus
exploit
technolog
includ
retrovirus
adenovirus
hsv
mani
preliminari
studi
report
encourag
result
howev
implement
gene
therapi
sever
tragic
compromis
death
patient
particip
clinic
trial
correct
congen
liver
defect
death
due
multipl
organ
failur
like
induc
sever
inflammatori
respons
adenoviru
vector
inde
sinc
demonstr
treat
isol
human
plasma
adenoviru
serotyp
concentr
match
reach
trial
activ
complement
level
could
result
vigor
inflammatori
respons
cichon
et
al
henc
comprehens
analysi
host
immun
respons
viral
vector
use
clinic
studi
need
evalu
consid
abil
host
elimin
vector
render
therapi
unsuccess
potenti
vector
induc
sever
inflammatori
respons
complement
may
play
signific
role
import
complement
control
viral
infect
evid
rang
strategi
utilis
virus
evad
complementmedi
attack
attenu
virul
virus
null
mutat
complementcontrol
protein
review
highlight
interact
virus
complement
mani
interact
complex
case
hiv
trigger
three
pathway
complement
activ
suscept
sever
result
effect
yet
also
evolv
rang
strategi
evad
complement
even
utilis
complement
enhanc
infect
mani
viral
protein
known
capabl
regul
complement
activ
may
serv
novel
therapeut
agent
treatment
complementmedi
diseas
viral
protein
identifi
base
homolog
known
cellular
regul
sever
known
homolog
cellular
protein
henc
may
viral
protein
mechan
complement
regul
similar
cellular
complement
regulatori
protein
provid
potenti
tool
dissect
complement
biolog
may
also
repres
class
complement
regulatori
protein
yet
discov
